Stay updated with breaking news from Biodesix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
19.12.2022 - Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced positive coverage decisions from four private payers including Blue Cross Blue Shield of North Carolina, Blue Cross Blue ... Seite 1
Biodesix, Inc. , a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the closing of its underwritten public offering of 35,075,000 shares of its common... | November 21, 2022
Biodesix (NASDAQ:BDSX – Get Rating) is one of 44 public companies in the “Medical laboratories” industry, but how does it weigh in compared to its competitors? We will compare Biodesix to related businesses based on the strength of its valuation, institutional ownership, analyst recommendations, profitability, dividends, risk and earnings. Valuation & Earnings This table compares […]
Philips Incorporates Biodesix blood-based Proteomic Nodule Risk Assessment Testing into Lung Cancer Orchestrator to Advance Early Lung Cancer Diagnosis
June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess the risk of lung nodule malignancy, enhancing decision-making for diagnosis